Growth Metrics

Oruka Therapeutics (ORKA) Property, Plant & Equipment (Net) Growth (3y) (2013 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PP&E (Net) Growth (3y) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -14.40%
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 3.41%
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -9.89%
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 13.10%
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 10.71%
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn -0.31%
10 Oruka Therapeutics 3.04 Bn 2.65 Bn - 147.40%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 147.40%
Dec 31, 2025 125.85%
Sep 30, 2025 103.55%
Jun 30, 2025 67.54%
Mar 31, 2025 54.64%
Dec 31, 2024 50.00%
Sep 30, 2024 49.38%
Jun 30, 2024 -55.37%
Mar 31, 2024 -36.24%
Dec 31, 2023 -21.91%
Sep 30, 2023 9.14%
Jun 30, 2023 12.31%
Mar 31, 2023 28.06%
Dec 31, 2022 35.72%
Sep 30, 2022 44.22%
Jun 30, 2022 41.72%
Mar 31, 2022 31.29%
Dec 31, 2021 25.99%
Sep 30, 2021 18.29%
Jun 30, 2021 10.89%
Mar 31, 2021 -9.97%
Dec 31, 2020 -20.63%
Sep 30, 2020 -40.72%
Jun 30, 2020 -39.43%
Mar 31, 2020 -44.66%
Dec 31, 2019 -46.69%
Sep 30, 2019 -47.47%
Jun 30, 2019 -44.49%
Mar 31, 2019 -7.49%
Dec 31, 2018 -5.01%
Sep 30, 2018 -2.20%
Jun 30, 2018 -0.99%
Mar 31, 2018 2.86%
Dec 31, 2017 5.27%
Sep 30, 2017 22.67%
Jun 30, 2017 23.03%
Mar 31, 2017 31.41%
Dec 31, 2016 31.54%
Sep 30, 2016 36.72%
Jun 30, 2016 53.53%
Mar 31, 2016 2.94%
Dec 31, 2015 6.78%
Sep 30, 2015 -2.06%
Jun 30, 2015 -7.53%
Mar 31, 2015 -13.21%
Dec 31, 2014 -18.29%
Sep 30, 2014 -46.10%
Jun 30, 2014 -61.03%
Dec 31, 2013 -65.23%